SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Sepsis/Acute Inflammation
An SI Board Since September 2001
Posts SubjectMarks Bans
89 16 0
Emcee:  scaram(o)uche Type:  Unmoderated
Scrapbook for news/publications related to sepsis and ACUTE inflammation.

Please avoid excessive chat and any off-topic discussion. Thanks!
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
89Singlet molecular oxygen regulates vascular tone and blood pressure in inflammatnigel bates15/14/2019
88Low dose topoisomerase 1 inhibitor possible effective treatment: science.sciencenigel bates-4/28/2016
87I follow the science closely, but don't make any effort to look for commerciscaram(o)uche-1/12/2015
86So do you follow this space in terms of companies developing products? Here'tuck-1/12/2015
85Very neat idea: nature.com Engineered liposomes sequester bacterial exotoxins anigel bates-11/4/2014
84cool.... Immunobiology. 2014 Sep 28. pii: S0171-2985(14)00178-8. doi: 10.1016/jscaram(o)uche-10/20/2014
83Hansa Medical and Axis-Shield report most promising results from pivotal clinicanigel bates-11/5/2013
82Science. 2013 Jul 25. [Epub ahead of print] Noncanonical Inflammasome Activatioscaram(o)uche-7/29/2013
81Cell. 2013 Jul 3;154(1):197-212. doi: 10.1016/j.cell.2013.06.013. A systems anascaram(o)uche-7/25/2013
80Nat Immunol. 2012 Nov;13(11):1045-54. doi: 10.1038/ni.2426. The p110d isoform oscaram(o)uche-7/19/2013
79Biochem Biophys Res Commun. 2013 Apr 10. pii: S0006-291X(13)00602-5. doi: 10.101scaram(o)uche-4/17/2013
78Am J Surg. 2013 Jan 30. pii: S0002-9610(13)00023-8. doi: 10.1016/j.amjsurg.2012.scaram(o)uche-2/6/2013
77London, UK, 8 August 2012: BTG plc (LSE: BTG), announces top-line data from a glnigel bates-8/8/2012
76<i>"While there were no new safety findings, the study failed to demoscaram(o)uche-10/25/2011
75J Pharmacol Exp Ther. 2011 Jun 14. [Epub ahead of print] Targeting cannabinoid scaram(o)uche-6/17/2011
74Br J Pharmacol. 2011 Mar 30. [Epub ahead of print] A new cannabinoid 2 receptorscaram(o)uche-4/19/2011
73J Physiol. 2011 Mar 14. [Epub ahead of print] The hypothermic response to bactescaram(o)uche-4/17/2011
72NVS Reports Positive Phase-3 Data for 4CMenB in Infants: siliconinvestor.comDewDiligence_on_SI-9/12/2010
71Immunology. 2010 Apr 6. [Epub ahead of print] Seladin-1 is a novel lipopolysaccscaram(o)uche-4/22/2010
70Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like rectnsaf-2/9/2009
69Contact: Emily Shafer emily.shafer@jefferson.edu 215-955-5291 <b>Jeffersoidos-1/23/2009
68Molecular Mechanisms Underlying the Role of Antithrombin in Sepsis: siliconinveDewDiligence_on_SI-5/19/2008
67Scripps scientists studying sepsis in mice find potential drug targets for deadlJohn McCarthy-2/28/2008
66Artisan Pharma’s ART-123 Approved for DIC in Japan: siliconinvestor.comDewDiligence_on_SI-2/22/2008
65The PD-1/PD-L costimulatory pathway critically affects host resistance to the patnsaf-2/13/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):